Header cover image

U.S. Healthtech Industry Analysis

UpdatedJun 18, 2024
DataAggregated Company Financials
Companies68
  • 7D-3.9%
  • 3M-18.1%
  • 1Y-20.5%
  • YTDn/a

Over the last 7 days, the Healthtech industry has dropped 3.9%, driven by a pullback from Veeva Systems of 2.8%. Meanwhile, LifeMD actually outperformed within the industry, gaining 11% in the last week. However, the industry is down 21% over the past year. As for the next few years, earnings are expected to grow by 27% per annum.

Industry Valuation and Performance

Has the U.S. Healthtech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 18 Jun 2024US$58.0bUS$13.7b-US$1,889,788,216.0047.3x-30.7x4.2x
Thu, 16 May 2024US$56.8bUS$12.8b-US$1,994,939,215.0050x-28.5x4.5x
Sat, 13 Apr 2024US$60.9bUS$12.7b-US$1,616,515,745.0048.4x-37.7x4.8x
Mon, 11 Mar 2024US$64.8bUS$14.1b-US$1,445,414,794.0050.5x-44.8x4.6x
Wed, 07 Feb 2024US$61.4bUS$13.8b-US$5,690,204,752.0059.5x-10.8x4.5x
Fri, 05 Jan 2024US$69.9bUS$18.3b-US$5,780,492,665.0052.9x-12.1x3.8x
Sun, 03 Dec 2023US$66.7bUS$18.2b-US$5,807,346,665.0053.2x-11.5x3.7x
Tue, 31 Oct 2023US$65.0bUS$18.1b-US$5,527,928,965.0049x-11.8x3.6x
Thu, 28 Sep 2023US$69.1bUS$18.0b-US$5,514,972,389.0051.5x-12.5x3.8x
Sat, 26 Aug 2023US$69.5bUS$17.9b-US$5,554,149,562.0051.9x-12.5x3.9x
Mon, 24 Jul 2023US$78.2bUS$17.7b-US$8,580,548,318.0060.9x-9.1x4.4x
Wed, 21 Jun 2023US$76.4bUS$17.7b-US$8,580,509,261.0063.3x-8.9x4.3x
Fri, 19 May 2023US$69.2bUS$17.7b-US$8,626,979,320.0059.4x-8x3.9x
Sun, 16 Apr 2023US$73.0bUS$17.4b-US$14,978,932,055.0057x-4.9x4.2x
Tue, 14 Mar 2023US$69.6bUS$17.7b-US$15,404,160,403.0051.2x-4.5x3.9x
Thu, 09 Feb 2023US$74.9bUS$17.5b-US$10,804,200,563.0052x-6.9x4.3x
Sat, 07 Jan 2023US$66.4bUS$17.5b-US$10,803,491,310.0042.6x-6.1x3.8x
Mon, 05 Dec 2022US$73.1bUS$17.5b-US$10,602,609,310.0049.5x-6.9x4.2x
Wed, 02 Nov 2022US$69.3bUS$17.2b-US$10,559,547,342.0035x-6.6x4x
Fri, 30 Sep 2022US$71.2bUS$17.1b-US$10,593,627,342.0032x-6.7x4.2x
Sun, 28 Aug 2022US$82.0bUS$17.0b-US$10,549,847,342.0033.6x-7.8x4.8x
Tue, 26 Jul 2022US$93.9bUS$17.4b-US$7,974,433,542.0060.3x-11.8x5.4x
Thu, 23 Jun 2022US$114.3bUS$23.2b-US$7,415,282,621.0049.8x-15.4x4.9x
Sat, 21 May 2022US$110.4bUS$23.1b-US$7,364,921,621.0046.1x-15x4.8x
Mon, 18 Apr 2022US$135.8bUS$23.4b-US$644,404,428.0069.1x-210.8x5.8x
Wed, 16 Mar 2022US$129.0bUS$23.9b-US$869,328,328.0076.3x-148.4x5.4x
Fri, 11 Feb 2022US$159.9bUS$23.9b-US$1,699,785,995.0094.1x-94.1x6.7x
Sun, 09 Jan 2022US$158.4bUS$23.7b-US$1,728,458,566.0097.4x-91.7x6.7x
Tue, 07 Dec 2021US$167.0bUS$23.1b-US$1,128,180,240.0098.7x-148x7.2x
Thu, 04 Nov 2021US$210.0bUS$22.6b-US$1,674,458,210.00109.6x-125.4x9.3x
Sat, 02 Oct 2021US$189.3bUS$22.1b-US$1,254,814,494.00103.9x-150.9x8.6x
Mon, 30 Aug 2021US$191.9bUS$21.9b-US$1,229,889,348.3191x-156x8.8x
Tue, 06 Jul 2021US$186.1bUS$21.8b-US$1,188,198,161.3194.7x-156.6x8.5x
Price to Earnings Ratio

-156.6x


Total Market Cap: US$186.1bTotal Earnings: -US$1,188,198,161.31Total Revenue: US$21.8bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthtech Industry Price to Earnings3Y Average -50.4x202220232024
Current Industry PE
  • Investors are pessimistic on the American Health Care Technology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 5.2x is higher than the industry's current PS ratio of 4.2x.
Past Earnings Growth
  • The earnings for companies in the Health Care Technology industry have deteriorated over the last three years.
  • Revenues have also declined 14% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Comparison

How does U.S. Healthtech compare with similar industries?

US Market1.61%
Healthcare-1.27%
Healthtech-3.85%
Healthtech-3.85%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LFMD LifeMDUS$8.4011.1%
+US$35.5m
149.3%PS2.2x
SLP Simulations PlusUS$47.021.2%
+US$11.2m
0.7%PE89.4x
SOPH SOPHiA GENETICSUS$4.953.1%
+US$9.8m
13.8%PS5x
TBRG TruBridgeUS$10.123.7%
+US$5.2m
-59.2%PS0.4x
MEDS TRxADE HEALTHUS$9.2455.4%
+US$4.6m
93.0%PS1.6x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CERT

US$14.37

Certara

7D

-8.9%

1Y

-17.2%

DOCS

US$28.08

Doximity

7D

-5.0%

1Y

-13.7%

SOPH

US$4.95

SOPHiA GENETICS

7D

3.1%

1Y

13.8%

GDRX

US$8.39

GoodRx Holdings

7D

-5.8%

1Y

46.7%

STRM

US$0.53

Streamline Health Solutions

7D

15.1%

1Y

-62.4%

SLP

US$47.02

Simulations Plus

7D

1.2%

1Y

0.7%

TDOC

US$10.11

Teladoc Health

7D

-5.2%

1Y

-59.4%

VEEV

US$179.75

Veeva Systems

7D

-2.8%

1Y

-10.1%

MEDS

US$9.24

TRxADE HEALTH

7D

55.4%

1Y

93.0%

FORA

US$2.69

Forian

7D

1.5%

1Y

17.0%

TRHC

US$10.50

Tabula Rasa HealthCare

7D

0.9%

1Y

203.5%